Mobile technology, wireless monitoring systems, RFID. LIMS and electronic notebook systems. Automation, QBAS, & process analytical technology. Service-oriented architecture & integration. Risk management and CAPA.
June 2, 2011
By:
Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
FDA added a searchable database of inspection data to its website. The database lists the names and addresses of facilities that the agency inspected during fiscal years 2009 and 2010.
|
June 1, 2011
By:
Markus Roemer
Pharmaceutical Technology Europe
In January 2011, the European Medicines Agency (EMA) announced the new revision of EudraLex Volume 4 (GMP) - Annex 11 'Computerised Systems', and the consequential amendment of EudraLex Volume 4 - Chapter 4 ?Documentation?.
|
June 1, 2011
By:
Orlando Lòpez
Pharmaceutical Technology Europe
In January 2011, a new version of Annex 11 was released by the European Commission along with a revision of Chapter 4 of its GMP on documentation to reflect the actualities of electronic record keeping, all of which come into full effect in June 2011.
|
May 2, 2011
By:
Erik Greb
Pharmaceutical Technology
Can the semiconductor industry help Big Pharma develop therapies?
|
May 1, 2011
By:
Tamara T. Monesmith
Pharmaceutical Technology
The authors developed automated equipment that uses functionally closed disposables to perform cellular and ribonucleic processing.
|
April 21, 2011
ePT--the Electronic Newsletter of Pharmaceutical Technology
Axcan acquires Mpex Pharmaceuticals; Bend Research receives patent for improving bioavailability of low-solubility drugs; and More.
|
April 6, 2011
By:
Patricia Van Arnum
PTSM: Pharmaceutical Technology Sourcing and Management
Eli Lilly and GlaxoSmithKline are among several pharmaceutical companies using technology transfer as way to improve health outcomes in the developing world.
|
March 3, 2011
ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.
|
March 3, 2011
By:
Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
FDA recently sent sanofi-aventis two Warning Letters for its facilities in Frankfurt am Main, Germany, and Bridgewater, NJ.
|
|
